Detalles de la búsqueda
1.
Immunogenicity and safety following one dose of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine in older adults: a phase 3 trial.
J Infect Dis
; 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38099559
2.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Clin Infect Dis
; 74(8): 1459-1467, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34283213
3.
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient-reported outcome system for vaccine safety remote monitoring.
Influenza Other Respir Viruses
; 17(3): e13098, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36991538
4.
Brand-Specific Enhanced Safety Surveillance Study of GSK's Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season.
Infect Dis Ther
; 11(1): 463-483, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34961900
5.
Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.
Drug Saf
; 44(12): 1375-1390, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34694589
6.
Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.
Drug Saf
; 43(3): 265-279, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31884676
Resultados
1 -
6
de 6
1
Próxima >
>>